Press release
Smoking Cessation Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - AXS-05, Cytisinicline, Nadolol (INV102), NFL-101, Liraglutide
The Smoking Cessation market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Smoking Cessation pipeline products will significantly revolutionize the Smoking Cessation market dynamics.
DelveInsight's "Smoking Cessation Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Smoking Cessation, historical and forecasted epidemiology as well as the Smoking Cessation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Smoking Cessation market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Smoking Cessation market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Smoking Cessation Market Insights https://www.delveinsight.com/report-store/smoking-cessation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Smoking Cessation Overview
Smoking cessation is the process of discontinuing tobacco smoking. When a person smokes tobacco in cigarettes, cigars or pipes, they absorb toxins that can lead to various health problems such as diabetes, cancer, chronic obstructive pulmonary disease (COPD), heart diseases, lung diseases, etc.
Some of the key facts of the Smoking Cessation Market Report:
• The Smoking Cessation market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• The total diagnosed prevalent population of Smoking Cessation in the 7MM was 50,808,171 cases in 2021
• The United States showed the highest diagnosed prevalent cases of smokers, as compared to EU5, and Japan. In 2021, number of smokers in the United States were estimated to be 33,088,399
• Key Smoking Cessation Companies: Axsome Therapeutics, Achieve Life Science, Chronic Airway Therapeutics, Smoke Free Therapeutics (NFL Biosciences SAS), Novo Nordisk, and others
• Key Smoking Cessation Therapies: AXS-05, Cytisinicline, Nadolol (INV102), NFL-101, Liraglutide, and others
• The Smoking cessation epidemiology based on gender analyzed that the diagnosed prevalence of smoking is higher in males as compared to females
Get a Free sample for the Smoking Cessation Market Report
https://www.delveinsight.com/sample-request/smoking-cessation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Key benefits of the Smoking Cessation Market report:
1. Smoking Cessation market report covers a descriptive overview and comprehensive insight of the Smoking Cessation Epidemiology and Smoking Cessation market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Smoking Cessation market report provides insights on the current and emerging therapies.
3. Smoking Cessation market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Smoking Cessation market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Smoking Cessation market.
Download the report to understand which factors are driving Smoking Cessation epidemiology trends @ Smoking Cessation Epidemiological Insights
https://www.delveinsight.com/sample-request/smoking-cessation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Smoking Cessation Market
The dynamics of the Smoking Cessation market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
"AXS-05, Cytisinicline (Cytisine), and NFL-101 are expected to enter in the market during the forecasted period (2022-2032). Cytisine has been used as a smoking cessation treatment inseveral Central and Eastern European countries since the 1960s, is inexpensive compared to other cessation medications and has few known side effects. With different forms, Cytisinicline is expected to enter in the US market in 2023."
Smoking Cessation Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Smoking Cessation Epidemiology Segmentation:
The Smoking Cessation market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Smoking Cessation
• Prevalent Cases of Smoking Cessation by severity
• Gender-specific Prevalence of Smoking Cessation
• Diagnosed Cases of Episodic and Chronic Smoking Cessation
Smoking Cessation Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Smoking Cessation market or expected to get launched during the study period. The analysis covers Smoking Cessation market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Smoking Cessation Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Smoking Cessation market share @ Smoking Cessation market forecast
https://www.delveinsight.com/sample-request/smoking-cessation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Smoking Cessation Therapies and Key Companies
• AXS-05: Axsome Therapeutics
• Cytisinicline: Achieve Life Science
• Nadolol (INV102): Chronic Airway Therapeutics
• NFL-101: Smoke Free Therapeutics (NFL Biosciences SAS)
• Liraglutide: Novo Nordisk
Smoking Cessation Market Drivers
• Research and Development
• Increase in awareness
• Government-mandated warnings on tobacco products
Scope of the Smoking Cessation Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Smoking Cessation Companies: Axsome Therapeutics, Achieve Life Science, Chronic Airway Therapeutics, Smoke Free Therapeutics (NFL Biosciences SAS), Novo Nordisk, and others
• Key Smoking Cessation Therapies: AXS-05, Cytisinicline, Nadolol (INV102), NFL-101, Liraglutide, and others
• Smoking Cessation Therapeutic Assessment: Smoking Cessation current marketed and Smoking Cessation emerging therapies
• Smoking Cessation Market Dynamics: Smoking Cessation market drivers and Smoking Cessation market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Smoking Cessation Unmet Needs, KOL's views, Analyst's views, Smoking Cessation Market Access and Reimbursement
Smoking Cessation Market Barriers
• Relapse Cases
• Social Attitudes and Personal Beliefs
• Social Network Barrier
• Patients are not able to use the benefit from Insurers and Health Plans
Table of Contents
1. Smoking Cessation Market Report Introduction
2. Executive Summary for Smoking Cessation
3. SWOT analysis of Smoking Cessation
4. Smoking Cessation Patient Share (%) Overview at a Glance
5. Smoking Cessation Market Overview at a Glance
6. Smoking Cessation Disease Background and Overview
7. Smoking Cessation Epidemiology and Patient Population
8. Country-Specific Patient Population of Smoking Cessation
9. Smoking Cessation Current Treatment and Medical Practices
10. Smoking Cessation Unmet Needs
11. Smoking Cessation Emerging Therapies
12. Smoking Cessation Market Outlook
13. Country-Wise Smoking Cessation Market Analysis (2019-2032)
14. Smoking Cessation Market Access and Reimbursement of Therapies
15. Smoking Cessation Market Drivers
16. Smoking Cessation Market Barriers
17. Smoking Cessation Appendix
18. Smoking Cessation Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Smoking Cessation treatment, visit @ Smoking Cessation Medications https://www.delveinsight.com/sample-request/smoking-cessation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Smoking Cessation Pipeline
https://www.delveinsight.com/report-store/smoking-cessation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Smoking Cessation Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Smoking Cessation market. A detailed picture of the Smoking Cessation pipeline landscape is provided, which includes the disease overview and Smoking Cessation treatment guidelines.
Smoking Cessation Epidemiology
https://www.delveinsight.com/report-store/smoking-cessation-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Smoking Cessation Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Smoking Cessation epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Trending Reports by DelveInsight
Ventricular Assist Devices Market
https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Smoking Cessation Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - AXS-05, Cytisinicline, Nadolol (INV102), NFL-101, Liraglutide here
News-ID: 2784870 • Views: …
More Releases from DelveInsight Business Research
Spinocerebellar Ataxias Pipeline 2025: Comprehensive Clinical Trials and Therapi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spinocerebellar Ataxias Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market.
The Spinocerebellar…
Presbyopia Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight O …
The Presbyopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Presbyopia pipeline products will significantly revolutionize the Presbyopia market dynamics.
DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Idiopathic Pulmonary Fibrosis Market Insights Highlight Expanding Outlook Till 2 …
DelveInsight's "Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Idiopathic Pulmonary Fibrosis, historical and forecasted epidemiology as well as the Idiopathic Pulmonary Fibrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Idiopathic Pulmonary Fibrosis, offering comprehensive insights into the Idiopathic Pulmonary Fibrosis revenue trends,…
Myocardial Infarction Market Positioned for Accelerated Development Through 2034 …
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Myocardial Infarction market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Myocardial Infarction Market Forecast
https://www.delveinsight.com/sample-request/myocardial-infarction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
More Releases for Smoking
FREESMO's 30-Day No Smoking Challenge: Stop Smoking This VApril
Bristol, UK - 26th March 2025
FREESMO is helping smokers make the switch this VApril with its 30-Day No Smoking Challenge - a structured, motivational program designed to support those looking to stop cigarettes for good. Coinciding with the UK's biggest vaping awareness campaign, the challenge offers tailored guidance, a supportive community, and incentives to keep participants committed.
Smokers are invited to complete FREESMO's unique Smoke-Free Questionnaire - a personalized tool matching…
Smoking Products & Smoking Alternatives Market Growing Popularity and Emerging T …
The global Smoking Products & Smoking Alternatives market size is estimated to be $859.1 billion in 2023, and HTF MI analysts predict it will reach $1046.7 billion by 2031, growing at a CAGR of 2.5% during the forecast period from 2023 to 2031.
Latest Study on Industrial Growth of Global Smoking Products & Smoking Alternatives Market 2024-2030. A detailed study accumulated to offer the Latest insights about acute features of the…
Smoking Products and Smoking Alternatives Market CAGR of 6.6 % Forecast 2030
Smoking products and smoking alternatives play a significant role in curing several human problems such as thyroid, stress relief, and others. This has been helping the market along with other major factors. The factor of growing smoking culture which drives hookah cafes and smoking lounges across the globe. Such a factor will upsurge the prevalence of smoking among youths and adults.
Browse Related Reports:
https://www.databridgemarketresearch.com/reports/global-smoking-products-and-smoking-alternatives-market
Top Trending Reports:
https://researchmarketpapers.blogspot.com/2023/11/cryptocurrency-banking-market-growth.html
https://researchmarketpapers.blogspot.com/2023/11/construction-and-demolition-waste.html
https://1234submission1234.blogspot.com/2023/11/smoking-products-and-smoking.html
Smoking products involves act…
Smoking Products and Smoking Alternatives Market Trajectory, Analytics Report, A …
Smoking products and smoking alternatives play a significant role in curing several human problems such as thyroid, stress relief, and others. This has been helping the market along with other major factors. The factor of growing smoking culture which drives hookah cafes and smoking lounges across the globe. Such a factor will upsurge the prevalence of smoking among youths and adults.
Full Access Of Report:
https://www.databridgemarketresearch.com/reports/global-smoking-products-and-smoking-alternatives-market
Top Trending Reports:
https://predatascience1234.blogspot.com/2023/09/acrylic-coating-additives-market.html
https://predatascience1234.blogspot.com/2023/09/advanced-packaging-technologies-market_28.html
https://predatascience1234.blogspot.com/2023/09/smoking-products-and-smoking_28.html
Data Bridge Market Research analyses…
Smoking Products and Smoking Alternatives Market Size, Share, Forecast, & Indust …
Data Bridge Market Research analyses that the global smoking products and smoking alternatives market is expected to reach a value of USD 1,491,228.44 million by 2030, at a CAGR of 6.6% during the forecast period. The global smoking products and smoking alternatives market report also comprehensively covers pricing analysis, patent analysis, and technological advancements.
Full Access Of Report:
https://www.databridgemarketresearch.com/reports/global-smoking-products-and-smoking-alternatives-market
Top Trending Report:
https://predatascience1234.blogspot.com/2023/09/radio-frequency-rf-diplexer-market.html
https://predatascience1234.blogspot.com/2023/09/security-system-at-workplace-market.html
https://predatascience1234.blogspot.com/2023/09/semiconductor-packaging-materials.html
https://predatascience1234.blogspot.com/2023/09/process-analytics-service-market.html
Smoking products involves act of inhaling and exhaling the fumes of…
Rising Awareness about Smoking Health Hazards and Smoking Cessation Therapy Driv …
The Centers for Disease Control and Prevention (CDC) reported that there were 44 million adults addicted to smoking in 2011 in the U.S. The majority of these addicts belonged to the low-income groups in the country. On a similar note, the World Health Organization stated that Europe has the biggest pool of smokers, while Asia Pacific has a high percentage of cigarette smokers in comparison to North America and Europe.…
